Here, through an integrated set of approaches, we identified the transient receptor potential melastatin 7 (TRPM7), a member of the TRP channel superfamily, as a gatekeeper of cellular glycolysis in glycolytic cancer and endothelial cells. The gene discussed is TRPM7; the disease is cancer.